Charles Schwab’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52M Sell
60,122
-54,604
-48% -$2.11M ﹤0.01% 2711
2026
Q1
$4.32M Buy
114,726
+13,426
+13% +$439K ﹤0.01% 2464
2025
Q4
$3.05M Buy
101,300
+40,809
+67% +$1.15M ﹤0.01% 2630
2025
Q3
$1.59M Buy
60,491
+21,897
+57% +$522K ﹤0.01% 2808
2025
Q2
$822K Buy
38,594
+11,686
+43% +$264K ﹤0.01% 2962
2025
Q1
$572K Buy
26,908
+56
+0.2% +$1.15K ﹤0.01% 3030
2024
Q4
$544K Buy
+26,852
New +$554K ﹤0.01% 3118

Other funds holding GRDN

Charles Schwab's GRDN Position: Q2 2026 in Review

Charles Schwab reduced its Guardian Pharmacy Services (GRDN) stake by 48% in Q2 2026, selling an estimated $2.11M and leaving 60,122 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

Charles Schwab first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.32M in Q1 2026. 189 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Charles Schwab held 60,122 shares of Guardian Pharmacy Services worth $2.52M as of Q2 2026.
  • Charles Schwab sold 54,604 Guardian Pharmacy Services shares in Q2 2026, an estimated $2.11M.
  • Guardian Pharmacy Services made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2711 holding.
  • Charles Schwab first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • Charles Schwab's Guardian Pharmacy Services position peaked at $4.32M in Q1 2026.
  • 189 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.